Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug Delivery System for Cannabinoids

This study is aimed at developing a Nanoemulsion formulation of a poorly water-soluble and thermally, oxidatively, and photolytically unstable active pharmaceutical ingredient (API) for ophthalmic application, specifically for the reduction of intraocular pressure (IOP) and to provide neuroprotection.

"*" indicates required fields

First Name*

Last Name*

Company*

State*